Rhythm Pharmaceuticals In... (RYTM)
59.95
0.72 (1.22%)
At close: Apr 23, 2025, 3:59 PM
59.84
-0.18%
After-hours: Apr 23, 2025, 05:42 PM EDT
Rhythm Pharmaceuticals Revenue Breakdown
| Period Ending | Mar 31, 2024 |
|---|---|
| Product Revenue | 25.97M |
| Product Revenue Growth | n/a |
Revenue by Geography
| Period Ending | Dec 31, 2023 |
|---|---|
| Germany Revenue | 6.08M |
| Germany Revenue Growth | n/a |
| Other Countries Revenue | 8.93M |
| Other Countries Revenue Growth | n/a |
| United States Revenue | 62.42M |
| United States Revenue Growth | n/a |
Operating Expense Breakdown
| Period Ending | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 35.38M | 36.41M | 34.38M | 32.37M | 30.48M | 30.05M | 24.63M | 26.32M | 21.94M | 22.33M | 21.45M | 21M | 17.51M | 15.46M | 14.52M | 13.12M | 11.29M | 8.92M | 12.8M | 9.41M | 10.54M | 8.84M | 7.76M | 8.39M | 8.54M | 6.44M | 4.71M | 4.33M | 2.31M | 1.36M | 1.52M | 2.74M | 982K | 1.11M | 1.47M | 2.02M | 922K | 239K | 239K |
| Selling, General, and Administrative Revenue Growth | -2.85% | +5.91% | +6.20% | +6.23% | +1.43% | +21.97% | -6.40% | +19.96% | -1.75% | +4.10% | +2.15% | +19.93% | +13.20% | +6.52% | +10.66% | +16.21% | +26.54% | -30.28% | +35.93% | -10.64% | +19.16% | +13.95% | -7.50% | -1.77% | +32.65% | +36.52% | +8.89% | +87.04% | +70.60% | -10.49% | -44.75% | +179.43% | -11.77% | -24.39% | -27.31% | +119.63% | +285.77% | 0.00% | n/a |
| Research and Development Revenue | 37.93M | 30.02M | 128.47M | 29.89M | 33.57M | 33.54M | 37.95M | 23.55M | 21.12M | 31.46M | 32.51M | 31.57M | 27.54M | 25.1M | 19.91M | 21.95M | 23M | 23M | 22.5M | 24.81M | 26.57M | 35.31M | 22.76M | 18.76M | 10.71M | 8.58M | 12.29M | 6.65M | 5.97M | 5.4M | 4.87M | 5.63M | 5.42M | 4.53M | 4.01M | 3.62M | 2.2M | 666K | 666K |
| Research and Development Revenue Growth | +26.37% | -76.64% | +329.79% | -10.96% | +0.08% | -11.60% | +61.14% | +11.52% | -32.87% | -3.24% | +2.96% | +14.65% | +9.70% | +26.08% | -9.31% | -4.53% | -0.01% | +2.19% | -9.29% | -6.63% | -24.74% | +55.12% | +21.31% | +75.27% | +24.71% | -30.13% | +84.67% | +11.42% | +10.64% | +10.75% | -13.46% | +3.91% | +19.52% | +13.07% | +10.83% | +64.60% | +230.03% | 0.00% | n/a |